Sterile Ceftriaxone Sodium
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- Category
- Other Pharmaceutical Chemicals
High Tech Pharm Co., Ltd.
- Country / Year Established
-
South Korea
/
- Business type
- Others
- Verified Certificate
-
16
| Product name | Sterile Ceftriaxone Sodium | Certification | - |
|---|---|---|---|
| Category | Other Pharmaceutical Chemicals | Ingredients | - |
| Keyword | - | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
Features
Sterile Ceftriaxone Sodium is one of Cephalosporine-related therapeutic antibiotics which is used for the treatment of patients infected with Gram positive(+) and Gram negative(-) bacteria. This drug is white crystalline powder and usually administered through intravenous and intramuscular route. This drug has a broad spectrum of therapeutic efficacy on bacteria such as Staphylococcus, Streptococcus, Pneumonia, Aeromonas, Citrobacter, Enterobacter, Pseudomonas, Neisseria etc.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Jeongsoo Kim
- Address
- 576-1, Sungbon-ri, Daeso-myeon,, Eumsung-gun, Chungcheongbuk-do, Korea
- Product Category
- Pharmaceuticals
- Company introduction
-
We, HIGH TECH PHARM. Co., Ltd. was established on 1st of April, 1998 as a joint venture company with ACS Dobfar, Italy and are specialized in manufacturing of Sterile Bulk Form of Cephalosporine- and Carbapenem-related Antibiotics. We have obtained the approval of Bulk Good Manufacturing Practice(BGMP) from Korea Food and Drug Administration (KFDA) in 21st of April, 2001.
So far, we had awards three times from Korean government as an excellent exporting company (award on US$1,000,000 of export in 2001, US$5,000,000 in 2003 and US$10,000,000 in 2004).
We are strictly manufacturing our products under BGMP regulation and are exporting most of them to overseas markets such as European (France, Italy, Switzerland, Portugal, Spain, Russia, Ukraine etc.), South American (Brazil, Argentina, Peru etc.), South Asian (Japan, Indonesia, Taiwan, Thailand, Singapore etc.) and African (Egypt, Tunisia etc.).
Now, we are planning to launch our products into North American Markets such as USA within two years and therefore, are preparing Drug Master File(DMF) to be submitted.
- Main Markets
-
Brazil
France
Germany
Hong Kong(China)
Italy
- Main Product
